The American Association for Cancer Research (AACR) is recognizing the founding members of The Cancer Genome Atlas (TCGA) and the current project team with 2020 AACR Team Science Awards. These teams will be honored during the AACR Virtual Annual Meeting II on June 24.
The Cancer Genome Atlas was launched in 2006 as a joint endeavor between the National Cancer Institute (NCI) and the National Human...
A deep sequencing study of brain metastases from MD Anderson revealed many similarities but also distinct differences relative to the primary...
In patients with leukemia, complete remission after treatment is currently defined by the absence of cancer cells in a bone marrow biopsy...
Immunotherapies have brought the potential for long-term remission and even cures to patients with many cancer types, but the benefits have not yet extended to all patients or all cancer types. Ovarian cancer is one such example.
MD Anderson’s Ovarian Cancer Moon Shot® seeks to change this by exploring the use of immunotherapy to bring lasting results to more patients.
Amir Jazaeri, M.D., professor of Gynecologic Oncology...
Chimeric antigen receptor (CAR) T cells were approved by the Food and Drug Administration (FDA) to treat relapsed and refractory large B-cell...
Cellular therapies have emerged as an effective new therapy for patients with certain types of cancer, and MD Anderson has played an important...
MD Anderson has created a new research platform to drive the discovery of new therapeutic agents for patients with leukemia by investigating...
Researchers at The University of Texas MD Anderson Cancer Center have discovered important mechanisms of drug resistance and metastasis in...
MD Anderson’s adoptive cell therapy (ACT) platform is advancing the next generation of cell-based immune therapies to bring innovative approaches...
Each year in the U.S., more than 50,000 people will be diagnosed with pancreatic cancer, which ranks around the 10th most common cancer type...